Navigation Links
Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
Date:11/6/2008

SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, endocrinology, oncology, and dermatology markets, today reported financial results for the three and nine months ended September 30, 2008.

"The fundamentals for Halozyme have never been stronger and I am pleased with the initiation of our Phase 2 insulin clinical trial. The study will test our proprietary rHuPH20 hyaluronidase enzyme with two commercially available insulins in diabetic patients," stated Jonathan Lim, M.D., President and CEO of Halozyme. "Other Halozyme clinical programs are also moving forward expeditiously and Phase 1 studies in our bisphosphonate and PEGPH20 programs should be starting soon. Our five proprietary programs focus on the development of first-in-class or best-in-class compounds that target large commercial markets and the initiation of additional human clinical studies should enhance the value of our pipeline and drive shareholder returns."

Recent Corporate and Scientific Achievements

-- A Phase 2 insulin clinical trial has been initiated in Type 1 diabetic patients that will compare glycemic control of a standardized liquid meal challenge and insulin pharmacokinetics after administration of each of four dosing regimens: Humulin(R) R (regular insulin human) with and without rHuPH20 and Humalog(R) (insulin lispro) with and without rHuPH20. The study is designed to detect faster absorption and a more rapid onset of action for both types of insulin when given in combination with Halozyme's rHuPH20 enzyme. Results should be available in mid-2009.

-- A clinical study in bladd
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
2. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
3. Halozyme Therapeutics to Present at Upcoming Investor Conferences
4. Halozyme Therapeutics to Host Research Day for Investors and Analysts
5. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
6. Halozyme Therapeutics to Present at Upcoming Investor Conferences
7. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
8. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
9. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, a ... technologies, today announced that it has been selected as ... Industry Association,s 2014 Awards for Excellence competition ... an independent panel of judges from SCORE (Counselors to ... winners will be honored at a gala event to ...
(Date:8/27/2014)... BIOEQUA, an innovative line of skin care ... handheld spray, has made its EQUA ESSENTIAL line available ... brand began with an unexpected discovery in an emergency ... that the application of nanospray technology allowed for liquid ... to skin's basal layer. This resulted in immediate absorption ...
(Date:8/27/2014)... White City, OR (PRWEB) August 27, 2014 ... Supply Report, “Consolidation continues to reshape the look and ... in nutrition. Consumer demand for higher-quality ingredients will push ... the North American market have experienced strong market growth ... and ethical attributes in their food and cosmetics to ...
(Date:8/27/2014)... WriteResult, LLC – a premier provider of ... superiority when it comes to meeting the needs of ... of their most recent study closeout on-time and with ... digital writing platform to collect Patient Reported Outcomes electronically ... drew data from a number of assessments including the ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... Data Generated From Both mRNA ... , Clustering analysis is ... a visual representation of complex data and a method for measuring ... for clustering , microarray data are: Hierarchical, K-means and Self-organizing ...
... now offers a complete Gene Expression Profiling Service* for Affymetrix , ... Full Service offering, , no project is ... consultation with Ambion's team of experienced array and ... Ambion's long history of providing innovative, , ...
... Isolate total RNA and protein from cultured cells or tissues ... nuclear and cytoplasmic RNA and protein from cultured , cells ... , Ambion's new PARIS Kit uses a fast, ... both RNA and native protein , from the same experimental ...
Cached Biology Technology:Analysis of Microarray Data 2Analysis of Microarray Data 3Analysis of Microarray Data 4Analysis of Microarray Data 5Analysis of Microarray Data 6Analysis of Microarray Data 7Ambion Offers Gene Expression Profiling Service 2Ambion Offers Gene Expression Profiling Service 3A Better Way to Isolate RNA AND Protein From the Same Sample 2A Better Way to Isolate RNA AND Protein From the Same Sample 3A Better Way to Isolate RNA AND Protein From the Same Sample 4A Better Way to Isolate RNA AND Protein From the Same Sample 5
(Date:8/27/2014)... Thousands of fishing traps are lost or abandoned each ... as derelict traps, which continue to catch fish, crabs, ... in losses to habitat, fisheries, and the watermen who ... to a newly published NOAA study. , The report, ... the first of its kind to examine the derelict ...
(Date:8/27/2014)... Happy Camp Complex of fires had consumed 24,939 acres ... consumed 35,530 as of eight hours ago. , ... Ranger District of the Klamath National Forest when a ... All but three of those fires are now 100 ... fires and their size at containment: Delta, 150 acres; ...
(Date:8/26/2014)... over a colony of harmful bacteria, biofilms make ... protected in a biofilm pose a significant health ... to treatment, and biofilm-protected bacteria account for some ... and are 50 to 1,000 times more resistant ... essence, we may have stumbled onto a magic ...
Breaking Biology News(10 mins):NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2Happy Camp and July Fire Complexes in California 2Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3
... According to a new report on regional marine research ... research about fisheries, ocean health, coastal hazards and climate ... protect the region,s annual $32-billion ocean-related economy, according to ... Grant programs. The report, West Coast Regional Marine ...
... German . , Several thousand test fields are ... They permit the rapid analysis of substances, e.g. for diagnosing ... use for DNA testing. When it comes to proteins, such ... have a defined three-dimensional structure by which they can interact ...
... Davis, CA Researchers from the University of California, Davis ... of the fragile X mental retardation 1 (FMR1) protein (FMRP), ... report by Iwahashi et al, "A quantitative ELISA assay for ... July 2009 issue of the Journal of Molecular Diagnostics ...
Cached Biology News:West Coast needs more research on fisheries, marine science, climate change 2Proteins in gel 2Measuring intellectual disability 2
Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
...
...
Buckets for tube holder inserts...
Biology Products: